Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase

Title: Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase
Authors: McGowan, Sheena; Porter, Corrine J.; Lowther, Jonathan; Stack, Colin M. (R12090); Golding, Sarah J.; Skinner-Adams, Tina S.; Trenholme, Katharine R.; Teuscher, Franka; Donnelly, Sheila; Grembecka, Jolanta; Mucha, Artur; Kafarski, Pawel; DeGori, Ross; Buckle, Ashley M.; Gardiner, Donald L.; Whisstock, James C.; Dalton, John P.
Publisher Information: U.S., National Academy of Sciences
Publication Year: 2009
Collection: University of Western Sydney (UWS): Research Direct
Subject Terms: 060104 - Cell Metabolism
Description: Plasmodium falciparum parasites are responsible for the major global disease malaria, which results in > 2 million deaths each year. With the rise of drug-resistant malarial parasites, novel drug targets and lead compounds are urgently required for the development of new therapeutic strategies. Here, we address this important problem by targeting the malarial neutral aminopeptidases that are involved in the terminal stages of hemoglobin digestion and essential for the provision of amino acids used for parasite growth and development within the erythrocyte. We characterize the structure and substrate specificity of one such aminopeptidase, PfA-M1, a validated drug target. The X-ray crystal structure of PfA-M1 alone and in complex with the generic inhibitor, bestatin, and a phosphinate dipeptide analogue with potent in vitro and in vivo antimalarial activity, hPheP[CH 2]Phe, reveals features within the protease active site that are critical to its function as an aminopeptidase and can be exploited for drug development. These results set the groundwork for the development of antimalarial therapeutics that target the neutral aminopeptidases of the parasite.
Document Type: article in journal/newspaper
File Description: print
Language: English
Relation: Proceedings of the National Academy of Sciences of the United States of America--0027-8424--1091-6490 Vol. 106 Issue. 8 pp: 2537-2542
DOI: 10.1073/pnas.0807398106
Availability: https://doi.org/10.1073/pnas.0807398106; http://hdl.handle.net/1959.7/uws:24553
Accession Number: edsbas.7D6FF948
Database: BASE